HK Stock Market Move | FS.COM (03355) falls over 3%; restricted shares officially lifted and begin trading today; the company has conducted multiple buybacks since inclusion in the Stock Connect.
FS.COM (03355) fell over 3%, down 3.14% as of press time, at HK$39.52, with a turnover of HK$9.3619 million.
FS.COM (03355) fell over 3%, down 3.14% as of press time, at HK$39.52, with a turnover of HK$9.3619 million.
On the news front, a total of 16.9229 million H-shares held by FS.COM's cornerstone investors, whose lock-up period ended on September 22, 2026, officially became tradable starting September 23. It is worth noting that the company has conducted buybacks for 10 consecutive days since its inclusion in the Stock Connect on September 7, repurchasing a total of 1.9027 million shares, with cumulative buyback amount of HK$75.529 million.
In the first half of this year, the company achieved revenue of RMB 1.762 billion, up 25.9% year-on-year; net profit of RMB 451 million, up 65.1% year-on-year; adjusted net profit of RMB 471 million, up 59.8% year-on-year. The sustained growth in performance during the period was mainly due to the continued surge in global AI computing power deployment and the construction and expansion demand for large-scale high-speed data centers, effectively driving the overall prosperity of the enterprise-level high-speed network equipment and supporting services industry.
Related Articles
.png)
M-Grass Ecology And Environment (300355.SZ) subsidiary wins bid for a 142 million yuan restoration project.

Hualan Biological Engineering, Inc. (002007.SZ) announced that the marketing authorization application for Trastuzumab for Injection of its affiliated company has been accepted.

HK Stock Market Move | LAOPU GOLD (06181) drops over 3% as precious metals recently come under pressure; Citi expects it to increase discounts, weighing on gross margin.
M-Grass Ecology And Environment (300355.SZ) subsidiary wins bid for a 142 million yuan restoration project.
.png)
Hualan Biological Engineering, Inc. (002007.SZ) announced that the marketing authorization application for Trastuzumab for Injection of its affiliated company has been accepted.

HK Stock Market Move | LAOPU GOLD (06181) drops over 3% as precious metals recently come under pressure; Citi expects it to increase discounts, weighing on gross margin.






